Selenylated Imidazo[1,2-a]pyridine Induces Cell Senescence and Oxidative Stress in Chronic Myeloid Leukemia Cells

Imidazo[1,2-a]pyridines (IPs) have been studied regarding drug development. The objective of this work was to evaluate the antileukemic capacity of IP derivatives by screening their ability as a pro-oxidant. IP derivatives were synthesized and oral bioavailability and toxicity were analyzed in silic...

Full description

Saved in:
Bibliographic Details
Published in:Molecules (Basel, Switzerland) Vol. 28; no. 2; p. 893
Main Authors: Burkner, Gabriella Teles, Dias, Dhébora Albuquerque, Souza, Kamylla Fernanda Souza de, Araújo, Anna Júlia Papa de, Basilio, Denise Caroline Luiz Soares, Jacobsen, Fernanda Tondello, Moraes, Ana Carolina Rabello de, Silva-Filho, Saulo Euclides, Cavalcante, Marcos Filipe de Oliveira, Moraes, Cassio Augusto de Oliveira, Saba, Sumbal, Macedo, Maria Lígia Rodrigues, Paredes-Gamero, Edgar Julian, Rafique, Jamal, Parisotto, Eduardo Benedetti
Format: Journal Article
Language:English
Published: Switzerland MDPI AG 01.01.2023
MDPI
Subjects:
Antineoplastic Agents - pharmacology
Apoptosis
Bioavailability
Breast cancer
Cancer therapies
Cell cycle
Cell growth
Cell Proliferation
Cellular Senescence
Chemotherapy
chronic myeloid leukemia
DNA damage
Drug development
Humans
imidazo[1,2-a]pyridines
K562 Cells
Kinases
Leukemia
Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy
Leukemia, Myeloid
Oxidative Stress
Pyridines - pharmacology
selenide
Senescence
Toxicity
senescence
leukemia
chronic myeloid leukemia
imidazo[1,2-a]pyridines
selenide
oxidative stress
ISSN:1420-3049, 1420-3049
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Imidazo[1,2-a]pyridines (IPs) have been studied regarding drug development. The objective of this work was to evaluate the antileukemic capacity of IP derivatives by screening their ability as a pro-oxidant. IP derivatives were synthesized and oral bioavailability and toxicity were analyzed in silico. Redox screening was performed on human Kasumi, KG-1, K562, and Jurkat leukemia cells. The IP derivative and the most responsive leukemic cell were selected for cytotoxicity, cell proliferation, cell senescence, and oxidative stress assays. The predictive toxicity analysis showed a possible effect on the reproductive system, but without mutagenic, carcinogenic, or irritability effects. MRK-107 against K562 cells was the compound that showed the best redox profile. MRK-107 did not induce cell death in K562 and monocyte cells. However, this compound was able to decrease cell proliferation and increase cell senescence after 48 and 72 h. Furthermore, MRK-107 induced oxidative stress in K562 cells after 72 h, increasing lipid peroxidation and decreasing reduced glutathione (GSH) contents. This study demonstrated that MRK-107-induced senescence with the involvement of oxidative stress is a possible mechanism of action, addressing this compound as a potential antitumor drug against chronic myeloid leukemia.
AbstractList Imidazo[1,2-a]pyridines (IPs) have been studied regarding drug development. The objective of this work was to evaluate the antileukemic capacity of IP derivatives by screening their ability as a pro-oxidant. IP derivatives were synthesized and oral bioavailability and toxicity were analyzed in silico. Redox screening was performed on human Kasumi, KG-1, K562, and Jurkat leukemia cells. The IP derivative and the most responsive leukemic cell were selected for cytotoxicity, cell proliferation, cell senescence, and oxidative stress assays. The predictive toxicity analysis showed a possible effect on the reproductive system, but without mutagenic, carcinogenic, or irritability effects. MRK-107 against K562 cells was the compound that showed the best redox profile. MRK-107 did not induce cell death in K562 and monocyte cells. However, this compound was able to decrease cell proliferation and increase cell senescence after 48 and 72 h. Furthermore, MRK-107 induced oxidative stress in K562 cells after 72 h, increasing lipid peroxidation and decreasing reduced glutathione (GSH) contents. This study demonstrated that MRK-107-induced senescence with the involvement of oxidative stress is a possible mechanism of action, addressing this compound as a potential antitumor drug against chronic myeloid leukemia.
Imidazo[1,2 ]pyridines (IPs) have been studied regarding drug development. The objective of this work was to evaluate the antileukemic capacity of IP derivatives by screening their ability as a pro-oxidant. IP derivatives were synthesized and oral bioavailability and toxicity were analyzed in silico. Redox screening was performed on human Kasumi, KG-1, K562, and Jurkat leukemia cells. The IP derivative and the most responsive leukemic cell were selected for cytotoxicity, cell proliferation, cell senescence, and oxidative stress assays. The predictive toxicity analysis showed a possible effect on the reproductive system, but without mutagenic, carcinogenic, or irritability effects. MRK-107 against K562 cells was the compound that showed the best redox profile. MRK-107 did not induce cell death in K562 and monocyte cells. However, this compound was able to decrease cell proliferation and increase cell senescence after 48 and 72 h. Furthermore, MRK-107 induced oxidative stress in K562 cells after 72 h, increasing lipid peroxidation and decreasing reduced glutathione (GSH) contents. This study demonstrated that MRK-107-induced senescence with the involvement of oxidative stress is a possible mechanism of action, addressing this compound as a potential antitumor drug against chronic myeloid leukemia.
Author Dias, Dhébora Albuquerque
Macedo, Maria Lígia Rodrigues
Rafique, Jamal
Araújo, Anna Júlia Papa de
Paredes-Gamero, Edgar Julian
Burkner, Gabriella Teles
Parisotto, Eduardo Benedetti
Jacobsen, Fernanda Tondello
Basilio, Denise Caroline Luiz Soares
Saba, Sumbal
Cavalcante, Marcos Filipe de Oliveira
Moraes, Ana Carolina Rabello de
Moraes, Cassio Augusto de Oliveira
Souza, Kamylla Fernanda Souza de
Silva-Filho, Saulo Euclides
AuthorAffiliation 1 Pharmaceutical Sciences, Food and Nutrition College, Federal University of Mato Grosso do Sul (UFMS), Campo Grande 79070-900, Brazil
5 Institute of Chemistry (INQUI), Federal University of Mato Grosso do Sul (UFMS), Campo Grande 79074-460, Brazil
2 Department of Biochemistry, Federal University of São Paulo, São Paulo 4044-020, Brazil
3 Department of Clinical Analysis, Center for Health Sciences, Federal University of Santa Catarina, Florianópolis 88040-970, Brazil
4 Institute of Chemistry (IQ), Federal University of Goiás (UFG), Goiania 74690-900, Brazil
AuthorAffiliation_xml – name: 4 Institute of Chemistry (IQ), Federal University of Goiás (UFG), Goiania 74690-900, Brazil
– name: 1 Pharmaceutical Sciences, Food and Nutrition College, Federal University of Mato Grosso do Sul (UFMS), Campo Grande 79070-900, Brazil
– name: 2 Department of Biochemistry, Federal University of São Paulo, São Paulo 4044-020, Brazil
– name: 3 Department of Clinical Analysis, Center for Health Sciences, Federal University of Santa Catarina, Florianópolis 88040-970, Brazil
– name: 5 Institute of Chemistry (INQUI), Federal University of Mato Grosso do Sul (UFMS), Campo Grande 79074-460, Brazil
Author_xml – sequence: 1
  givenname: Gabriella Teles
  surname: Burkner
  fullname: Burkner, Gabriella Teles
– sequence: 2
  givenname: Dhébora Albuquerque
  orcidid: 0000-0002-3636-1970
  surname: Dias
  fullname: Dias, Dhébora Albuquerque
– sequence: 3
  givenname: Kamylla Fernanda Souza de
  surname: Souza
  fullname: Souza, Kamylla Fernanda Souza de
– sequence: 4
  givenname: Anna Júlia Papa de
  surname: Araújo
  fullname: Araújo, Anna Júlia Papa de
– sequence: 5
  givenname: Denise Caroline Luiz Soares
  surname: Basilio
  fullname: Basilio, Denise Caroline Luiz Soares
– sequence: 6
  givenname: Fernanda Tondello
  orcidid: 0000-0002-6549-8992
  surname: Jacobsen
  fullname: Jacobsen, Fernanda Tondello
– sequence: 7
  givenname: Ana Carolina Rabello de
  orcidid: 0000-0003-1088-472X
  surname: Moraes
  fullname: Moraes, Ana Carolina Rabello de
– sequence: 8
  givenname: Saulo Euclides
  orcidid: 0000-0002-9676-7622
  surname: Silva-Filho
  fullname: Silva-Filho, Saulo Euclides
– sequence: 9
  givenname: Marcos Filipe de Oliveira
  surname: Cavalcante
  fullname: Cavalcante, Marcos Filipe de Oliveira
– sequence: 10
  givenname: Cassio Augusto de Oliveira
  orcidid: 0000-0002-4470-1955
  surname: Moraes
  fullname: Moraes, Cassio Augusto de Oliveira
– sequence: 11
  givenname: Sumbal
  orcidid: 0000-0002-6134-7249
  surname: Saba
  fullname: Saba, Sumbal
– sequence: 12
  givenname: Maria Lígia Rodrigues
  surname: Macedo
  fullname: Macedo, Maria Lígia Rodrigues
– sequence: 13
  givenname: Edgar Julian
  orcidid: 0000-0003-3686-8402
  surname: Paredes-Gamero
  fullname: Paredes-Gamero, Edgar Julian
– sequence: 14
  givenname: Jamal
  orcidid: 0000-0002-2336-040X
  surname: Rafique
  fullname: Rafique, Jamal
– sequence: 15
  givenname: Eduardo Benedetti
  orcidid: 0000-0001-5934-0323
  surname: Parisotto
  fullname: Parisotto, Eduardo Benedetti
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36677949$$D View this record in MEDLINE/PubMed
BookMark eNp9kktv1DAUhSNURB_wA9ggS2wJ-JHE8QYJjaCMNKiLgRVClh83rQfHntpJxfTX43ZK1YLEylf2Od_10b3H1UGIAarqJcFvGRP43Rg9mNlDpj2muBfsSXVEGoprhhtx8KA-rI5z3mBMSUPaZ9Uh6zrORSOOqss1eAg7ryawaDk6q67jd_KG1urHdpecdQHQMtjZQEYL8B6tIUA2EAwgFSw6-1Usk7sCtJ4S5IxcQIuLFIMz6MsOfHQWrWD-CaNTt4D8vHo6KJ_hxd15Un379PHr4nO9OjtdLj6satN0eKq5bYXRnRHQtH2jrVWUmYZj0WhGWQ-cUAtCD7SUVABVRmGNQWtmesoJsJNquefaqDZym9yo0k5G5eTtRUznUqXJGQ-SGAUFJrTpbKNBadEBEYxDSzkd9FBY7_es7axHsCX-lJR_BH38EtyFPI9XUvQd7nteAK_vAClezpAnuYlzCiW_pLzjtORqSVG9etjmnv9nXEVA9gKTYs4JhnsJwfJmJeQ_K1E8_C-PcVMZWbz5qfP_cf4GBM3BGg
CitedBy_id crossref_primary_10_3390_antiox13040461
crossref_primary_10_3390_molecules28166136
crossref_primary_10_1186_s12943_025_02284_z
crossref_primary_10_3390_ph16060814
crossref_primary_10_1590_0001_3765202420230375
crossref_primary_10_1002_ajoc_202500508
crossref_primary_10_2174_0113816128280082231205071504
Cites_doi 10.1016/0022-1759(83)90303-4
10.1159/000447076
10.1002/chem.201600800
10.1021/acs.analchem.7b00043
10.1038/cddis.2014.82
10.1021/ml300282t
10.1002/chem.201705404
10.1007/s11064-020-03026-x
10.1038/s41598-020-72129-w
10.1155/2013/296792
10.1016/j.dnarep.2015.10.004
10.18632/oncotarget.14085
10.3390/molecules26154446
10.1021/acs.jmedchem.9b01736
10.1002/cncr.26679
10.1021/jm020017n
10.1002/jbt.22663
10.1038/nrc3773
10.1055/a-1021-0611
10.1080/152165499307404
10.1089/scd.2009.0313
10.1016/j.tcb.2018.04.006
10.1007/s11696-020-01383-z
10.1021/ml500244m
10.1080/15384101.2019.1652047
10.1002/anie.202104503
10.1038/s41556-018-0249-2
10.1073/pnas.92.20.9363
10.1002/chem.201905308
10.1016/j.ddtec.2004.11.007
10.1016/j.cell.2019.10.005
10.1016/j.bbrc.2018.07.039
10.1016/j.bbrc.2019.05.098
10.1155/2020/5417024
10.1016/j.tet.2018.05.084
10.1016/j.bbrc.2013.03.028
10.1002/ejoc.201900992
10.1039/C7OB03177G
10.3892/or.2013.2499
10.1038/nrm3823
10.1038/s41568-021-00355-z
10.1093/jpp/rgaa070
10.1016/j.dyepig.2020.108519
10.1002/slct.201801213
10.1155/2021/7753857
10.1016/j.pharmthera.2010.09.008
10.1007/s11064-016-2008-8
10.3390/ijms21124346
10.1038/nature03098
ContentType Journal Article
Copyright 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2023 by the authors. 2023
Copyright_xml – notice: 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2023 by the authors. 2023
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
5PM
DOA
DOI 10.3390/molecules28020893
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials - QC
ProQuest Central
ProQuest One Community College
ProQuest Central Korea
Proquest Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
Medical Database
Proquest Central Premium
ProQuest One Academic (New)
ProQuest Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
DatabaseTitleList
Publicly Available Content Database

MEDLINE
CrossRef
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: PIMPY
  name: Publicly Available Content Database
  url: http://search.proquest.com/publiccontent
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
EISSN 1420-3049
ExternalDocumentID oai_doaj_org_article_1caede99bc6d4beab96e1937e5272fbf
PMC9860887
36677949
10_3390_molecules28020893
Genre Journal Article
GrantInformation_xml – fundername: Fundação de Apoio a Pesquisa do Estado de Goiás
  grantid: Call No. 01/2022, No.: 210, and Call No. 01/2022, No.: 223
– fundername: Coordenação de Aperfeicoamento de Pessoal de Nível Superior
  grantid: 001
– fundername: National Council for Scientific and Technological Development
  grantid: 315399/2020-1, 422645/2021-4, 309975/2022-0, and 403210/2021-6
– fundername: Fundação de Apoio a Pesquisa-(FUNAPE-UFG)
  grantid: 01/2022; 210; 01/2022; 223
– fundername: Fundação de Apoio ao Desenvolvimento do Ensino, Ciência e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT-MS)
– fundername: Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
  grantid: 315399/2020-1; 422645/2021-4; 309975/2022-0; 403210/2021-6
– fundername: FUNDECT–S
  grantid: 266/2022
– fundername: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior-Brasil
  grantid: 001
– fundername: Universidade Federal de Mato Grosso do Sul (UFMS)
GroupedDBID ---
0R~
123
2WC
53G
5VS
7X7
88E
8FE
8FG
8FH
8FI
8FJ
A8Z
AADQD
AAFWJ
AAHBH
AAYXX
ABDBF
ABUWG
ACGFO
ACIWK
ACPRK
ACUHS
AEGXH
AENEX
AFFHD
AFKRA
AFPKN
AFRAH
AFZYC
AIAGR
ALMA_UNASSIGNED_HOLDINGS
BENPR
BPHCQ
BVXVI
CCPQU
CITATION
CS3
D1I
DIK
DU5
E3Z
EBD
EMOBN
ESTFP
ESX
FYUFA
GROUPED_DOAJ
GX1
HH5
HMCUK
HYE
HZ~
I09
IAO
IHR
ITC
KQ8
LK8
M1P
MODMG
O-U
O9-
OK1
P2P
PHGZM
PHGZT
PIMPY
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
RPM
SV3
TR2
TUS
UKHRP
~8M
3V.
ABJCF
ALIPV
BBNVY
BHPHI
CGR
CUY
CVF
ECM
EIF
HCIFZ
KB.
M7P
M~E
NPM
PDBOC
7XB
8FK
AZQEC
DWQXO
K9.
PKEHL
PQEST
PQUKI
PRINS
5PM
ID FETCH-LOGICAL-c460t-7d59cb6c9e4584bdda23c47094b3238e712de9bf28e729e2aca0b0ebb3c8271e3
IEDL.DBID DOA
ISICitedReferencesCount 13
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000918701700001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1420-3049
IngestDate Tue Oct 14 18:50:02 EDT 2025
Tue Nov 04 02:06:40 EST 2025
Tue Oct 07 07:23:19 EDT 2025
Wed Feb 19 02:25:28 EST 2025
Sat Nov 29 07:19:42 EST 2025
Tue Nov 18 22:41:11 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords senescence
leukemia
chronic myeloid leukemia
imidazo[1,2-a]pyridines
selenide
oxidative stress
Language English
License Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c460t-7d59cb6c9e4584bdda23c47094b3238e712de9bf28e729e2aca0b0ebb3c8271e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ORCID 0000-0002-3636-1970
0000-0002-2336-040X
0000-0003-1088-472X
0000-0002-6549-8992
0000-0002-4470-1955
0000-0002-9676-7622
0000-0002-6134-7249
0000-0003-3686-8402
0000-0001-5934-0323
OpenAccessLink https://doaj.org/article/1caede99bc6d4beab96e1937e5272fbf
PMID 36677949
PQID 2767270951
PQPubID 2032355
ParticipantIDs doaj_primary_oai_doaj_org_article_1caede99bc6d4beab96e1937e5272fbf
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9860887
proquest_journals_2767270951
pubmed_primary_36677949
crossref_primary_10_3390_molecules28020893
crossref_citationtrail_10_3390_molecules28020893
PublicationCentury 2000
PublicationDate 2023-01-01
PublicationDateYYYYMMDD 2023-01-01
PublicationDate_xml – month: 01
  year: 2023
  text: 2023-01-01
  day: 01
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
– name: Basel
PublicationTitle Molecules (Basel, Switzerland)
PublicationTitleAlternate Molecules
PublicationYear 2023
Publisher MDPI AG
MDPI
Publisher_xml – name: MDPI AG
– name: MDPI
References Zhong (ref_38) 2019; 514
Rafique (ref_30) 2022; 2022
Galant (ref_19) 2021; 46
Lowe (ref_44) 2004; 432
Dimri (ref_56) 1995; 92
Scheide (ref_26) 2020; 10
Young (ref_31) 2014; 14
Saba (ref_51) 2018; 16
ref_17
Rafique (ref_48) 2016; 22
Grek (ref_28) 2011; 129
Veloso (ref_15) 2021; 73
Semreen (ref_16) 2016; 37
Baraibar (ref_45) 2014; 75
Bettanin (ref_49) 2018; 74
Kapor (ref_39) 2021; 2021
Frizon (ref_12) 2020; 2020
Franco (ref_20) 2021; 60
Parisotto (ref_46) 2016; 41
Gomes (ref_57) 2020; 75
Bird (ref_58) 1984; 90
Lee (ref_32) 2019; 21
ref_24
Lipinski (ref_27) 2004; 1
Meirinho (ref_23) 2019; 2019
Felipe (ref_18) 2013; 433
Chen (ref_8) 2013; 4
Rafique (ref_14) 2021; 35
Beutler (ref_59) 1963; 61
Zou (ref_10) 2014; 5
ref_36
Ferreira (ref_55) 2020; 86
Dong (ref_40) 2014; 5
Whiteley (ref_2) 2021; 21
Mosmann (ref_54) 1983; 65
Yu (ref_11) 2020; 63
Rafique (ref_50) 2018; 24
Sieben (ref_43) 2018; 28
Lee (ref_7) 2013; 30
Kona (ref_47) 2013; 2013
Saba (ref_21) 2020; 26
Zhai (ref_41) 2017; 8
Veber (ref_52) 2002; 45
Juliusson (ref_1) 2016; 43
Reiniers (ref_53) 2017; 89
Gorgoulis (ref_34) 2019; 179
Guillon (ref_33) 2019; 18
Huang (ref_6) 2012; 118
Peterle (ref_22) 2018; 3
ref_3
Guo (ref_37) 2010; 19
Davies (ref_29) 1999; 48
Jeong (ref_9) 2011; 5
Rafique (ref_25) 2020; 180
Almeida (ref_13) 2018; 503
Serrano (ref_35) 2014; 15
ref_5
ref_4
Geng (ref_42) 2018; 42
References_xml – volume: 5
  start-page: 299
  year: 2011
  ident: ref_9
  article-title: Bimodal actions of selenium essential for antioxidant and toxic pro-oxidant activities: The selenium paradox (Review)
  publication-title: Mol. Med. Rep.
– ident: ref_5
– volume: 65
  start-page: 55
  year: 1983
  ident: ref_54
  article-title: Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
  publication-title: J. Immunol. Methods
  doi: 10.1016/0022-1759(83)90303-4
– volume: 43
  start-page: 87
  year: 2016
  ident: ref_1
  article-title: Leukemia
  publication-title: Prog. Tumor Res.
  doi: 10.1159/000447076
– volume: 22
  start-page: 11854
  year: 2016
  ident: ref_48
  article-title: Braga. Regioselective, Solvent- and Metal-Free Chalcogenation of Imidazo[1,2-a ]pyridines by Employing I2/DMSO as the Catalytic Oxidation System
  publication-title: Chem. Eur. J.
  doi: 10.1002/chem.201600800
– volume: 89
  start-page: 3853
  year: 2017
  ident: ref_53
  article-title: Preparation and Practical Applications of 2′,7′-Dichlorodihydrofluorescein in Redox Assays
  publication-title: Anal. Chem.
  doi: 10.1021/acs.analchem.7b00043
– volume: 5
  start-page: e1116
  year: 2014
  ident: ref_40
  article-title: A stress-induced cellular aging model with postnatal neural stem cells
  publication-title: Cell Death Dis.
  doi: 10.1038/cddis.2014.82
– volume: 4
  start-page: 69
  year: 2013
  ident: ref_8
  article-title: Synthesis and anti-in flammatory evaluation of novel benzimidazole and imidazopyridine derivatives
  publication-title: ACS Med. Chem. Lett.
  doi: 10.1021/ml300282t
– volume: 24
  start-page: 4173
  year: 2018
  ident: ref_50
  article-title: Direct, Metal-free C(sp2)−H Chalcogenation of Indoles and Imidazopyridines with Dichalcogenides Catalysed by KIO3
  publication-title: Chem. Eur. J.
  doi: 10.1002/chem.201705404
– volume: 46
  start-page: 120
  year: 2021
  ident: ref_19
  article-title: The Thiol-Modifier Effects of Organoselenium Compounds and Their Cytoprotective Actions in Neuronal Cells
  publication-title: Neurochem. Res.
  doi: 10.1007/s11064-020-03026-x
– volume: 10
  start-page: 15233
  year: 2020
  ident: ref_26
  article-title: Borophosphate glass as an active media for CuO nanoparticle growth: An efficient catalyst for selenylation of oxadiazoles and application in redox reactions
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-020-72129-w
– volume: 2013
  start-page: 296792
  year: 2013
  ident: ref_47
  article-title: A Convenient Synthesis of C-3-Aryloxymethyl Imidazo[1,2-a]Pyridine Derivatives
  publication-title: J. Chem.
  doi: 10.1155/2013/296792
– volume: 37
  start-page: 1
  year: 2016
  ident: ref_16
  article-title: Modulation of DNA damage response and induction of apoptosis mediates synergism between doxorubicin and a new imidazopyridine derivative in breast and lung cancer cells
  publication-title: DNA Repair
  doi: 10.1016/j.dnarep.2015.10.004
– volume: 8
  start-page: 7276
  year: 2017
  ident: ref_41
  article-title: Drug-induced premature senescence model in human dental follicle stem cells
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.14085
– volume: 61
  start-page: 882
  year: 1963
  ident: ref_59
  article-title: Improved method for the determination of blood glutathione
  publication-title: J. Lab. Clin. Med.
– ident: ref_24
  doi: 10.3390/molecules26154446
– ident: ref_4
– volume: 63
  start-page: 3028
  year: 2020
  ident: ref_11
  article-title: Design, synthesis, and biological evaluation of imidazo[1,2-a]pyridine derivatives as novel PI3K/mTOR dual inhibitors
  publication-title: J. Med. Chem.
  doi: 10.1021/acs.jmedchem.9b01736
– volume: 118
  start-page: 3123
  year: 2012
  ident: ref_6
  article-title: Estimations of the increasing prevalence and plateau prevalence of chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy
  publication-title: Cancer
  doi: 10.1002/cncr.26679
– volume: 45
  start-page: 2615
  year: 2002
  ident: ref_52
  article-title: Molecular Properties That Influence the Oral Bioavailability of Drug Candidates
  publication-title: J. Med. Chem.
  doi: 10.1021/jm020017n
– volume: 35
  start-page: e22663
  year: 2021
  ident: ref_14
  article-title: Apoptosis oxidative damage-mediated and antiproliferative effect of selenylated imidazo[1,2-a]pyridines on hepatocellular carcinoma HepG2 cells and in vivo
  publication-title: J. Biochem. Mol. Toxicol.
  doi: 10.1002/jbt.22663
– volume: 14
  start-page: 547
  year: 2014
  ident: ref_31
  article-title: Inside and out: The activities of senescence in cancer
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/nrc3773
– volume: 86
  start-page: 55
  year: 2020
  ident: ref_55
  article-title: Eglerisine, a Novel Sesquiterpenoid Tropolone from Dulacia egleri with Antiproliferative Effect against an Acute Myeloid Leukemia Lineage
  publication-title: Planta Med.
  doi: 10.1055/a-1021-0611
– volume: 48
  start-page: 41
  year: 1999
  ident: ref_29
  article-title: The broad spectrum of responses to oxidants in proliferating cells: A new paradigm for oxidative stress
  publication-title: IUBMB Life
  doi: 10.1080/152165499307404
– volume: 19
  start-page: 1321
  year: 2010
  ident: ref_37
  article-title: Effects of Oxidative Stress on Mouse Embryonic Stem Cell Proliferation, Apoptosis, Senescence, and Self-Renewal
  publication-title: Stem Cells Dev.
  doi: 10.1089/scd.2009.0313
– volume: 28
  start-page: 723
  year: 2018
  ident: ref_43
  article-title: Two-Step Senescence-Focused Cancer Therapies
  publication-title: Trends Cell Biol.
  doi: 10.1016/j.tcb.2018.04.006
– volume: 75
  start-page: 1211
  year: 2020
  ident: ref_57
  article-title: Thiopyrimidine derivatives induce cytotoxicity, cell cycle arrest and oxidative stress in breast cancer 3D-spheroids
  publication-title: Chem. Pap.
  doi: 10.1007/s11696-020-01383-z
– volume: 5
  start-page: 947
  year: 2014
  ident: ref_10
  article-title: Lead Optimization of Imidazopyrazines: A New Class of Antimalarial with Activity on Plasmodium Liver Stages
  publication-title: ACS Med. Chem. Lett.
  doi: 10.1021/ml500244m
– ident: ref_3
– volume: 18
  start-page: 2385
  year: 2019
  ident: ref_33
  article-title: Chemotherapy-induced senescence, an adaptive mechanism driving resistance and tumor heterogeneity
  publication-title: Cell Cycle
  doi: 10.1080/15384101.2019.1652047
– volume: 60
  start-page: 18454
  year: 2021
  ident: ref_20
  article-title: KIO4-mediated Selective Hydroxymethylation/Methylenation of Imidazo-Heteroarenes: A Greener Approach
  publication-title: Angew. Chem. Int. Ed. Engl.
  doi: 10.1002/anie.202104503
– volume: 21
  start-page: 94
  year: 2019
  ident: ref_32
  article-title: The dynamic nature of senescence in cancer
  publication-title: Nat. Cell Biol.
  doi: 10.1038/s41556-018-0249-2
– volume: 92
  start-page: 9363
  year: 1995
  ident: ref_56
  article-title: A biomarker that identifies senescent human cells in culture and in aging skin in vivo
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.92.20.9363
– volume: 26
  start-page: 4461
  year: 2020
  ident: ref_21
  article-title: Photoinduced, Direct C(sp2)−H Bond Azo Coupling of Imidazoheteroarenes and Imidazoanilines with Aryl Diazonium Salts Catalyzed by Eosin Y
  publication-title: Chem. Eur. J.
  doi: 10.1002/chem.201905308
– volume: 1
  start-page: 337
  year: 2004
  ident: ref_27
  article-title: Lead- and drug-like compounds: The rule-of-five revolution
  publication-title: Drug Discov. Today Technol.
  doi: 10.1016/j.ddtec.2004.11.007
– volume: 179
  start-page: 813
  year: 2019
  ident: ref_34
  article-title: Cellular Senescence: Defining a Path Forward
  publication-title: Cell
  doi: 10.1016/j.cell.2019.10.005
– volume: 503
  start-page: 1291
  year: 2018
  ident: ref_13
  article-title: Novel selenylated imidazo[1,2- a ]pyridines for breast cancer chemotherapy: Inhibition of cell proliferation by Akt-mediated regulation, DNA cleavage and apoptosis
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2018.07.039
– volume: 90
  start-page: 105
  year: 1984
  ident: ref_58
  article-title: Comparative studies on different methods of malondyhaldehyde determination
  publication-title: Methods Enzymol.
– volume: 514
  start-page: 1204
  year: 2019
  ident: ref_38
  article-title: Oxidative stress induces senescence in breast cancer stem cells
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2019.05.098
– volume: 75
  start-page: S23
  year: 2014
  ident: ref_45
  article-title: Impaired energy metabolism of senescent muscle satellite cells is associated with oxidative modifications of glycolytic enzymes
  publication-title: Free Radic. Biol. Med.
– volume: 2020
  start-page: 5417024
  year: 2020
  ident: ref_12
  article-title: Synthesis of Novel Selenocyanates and Evaluation of Their Effect in Cultured Mouse Neurons Submitted to Oxidative Stress
  publication-title: Oxidative Med. Cell Longev.
  doi: 10.1155/2020/5417024
– volume: 74
  start-page: 3971
  year: 2018
  ident: ref_49
  article-title: NH4I-catalyzed chalcogen(S/Se)-functionalization of 5-membered N-heteroaryls under metal-free conditions
  publication-title: Tetrahedron
  doi: 10.1016/j.tet.2018.05.084
– volume: 433
  start-page: 573
  year: 2013
  ident: ref_18
  article-title: Antiproliferative effects of phenylaminonaphthoquinones are increased by ascorbate and associated with the appearance of a senescent phenotype in human bladder cancer cells
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2013.03.028
– volume: 2019
  start-page: 6465
  year: 2019
  ident: ref_23
  article-title: Electrochemical Oxidative C(sp2)–H Bond Selenylation of Activated Arenes
  publication-title: Eur. J. Org. Chem.
  doi: 10.1002/ejoc.201900992
– volume: 16
  start-page: 880
  year: 2018
  ident: ref_51
  article-title: Rose Bengal catalysed photo-induced selenylation of indoles, imidazoles and arenes: A metal free approach
  publication-title: Org. Biomol. Chem.
  doi: 10.1039/C7OB03177G
– volume: 30
  start-page: 863
  year: 2013
  ident: ref_7
  article-title: A novel imidazopyridine PI3K inhibitor with anticancer activity in non-small cell lung cancer cells
  publication-title: Oncol. Rep.
  doi: 10.3892/or.2013.2499
– volume: 42
  start-page: 3522
  year: 2018
  ident: ref_42
  article-title: Adjudin delays cellular senescence through Sirt3-mediated attenuation of ROS production
  publication-title: Int. J. Mol. Med.
– volume: 2022
  start-page: 3710449
  year: 2022
  ident: ref_30
  article-title: IP-Se-06, a Selenylated Imidazo [1, 2-a] pyridine, Modulates Intracellular Redox State and Causes Akt/mTOR/HIF-1α and MAPK Signaling Inhibition, Promoting Antiproliferative Effect and Apoptosis in Glioblastoma Cells
  publication-title: Oxid. Med. Cell Longev.
– volume: 15
  start-page: 482
  year: 2014
  ident: ref_35
  article-title: Cellular senescence: From physiology to pathology
  publication-title: Nat. Rev. Mol. Cell Biol.
  doi: 10.1038/nrm3823
– volume: 21
  start-page: 461
  year: 2021
  ident: ref_2
  article-title: Leukaemia: A model metastatic disease
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/s41568-021-00355-z
– volume: 73
  start-page: 673
  year: 2021
  ident: ref_15
  article-title: A selanylimidazopyridine (3-SePh-IP) reverses the prodepressant- and anxiogenic-like effects of a high-fat/high-fructose diet in mice
  publication-title: J. Pharm. Pharmacol.
  doi: 10.1093/jpp/rgaa070
– volume: 180
  start-page: 108519
  year: 2020
  ident: ref_25
  article-title: Selenylated-oxadiazoles as promising DNA intercalators: Synthesis, electronic structure, DNA interaction and cleavage
  publication-title: Dye. Pigment.
  doi: 10.1016/j.dyepig.2020.108519
– volume: 3
  start-page: 13191
  year: 2018
  ident: ref_22
  article-title: Copper-Catalyzed Three-Component Reaction of Oxadiazoles, Elemental Se/S and Aryl Iodides: Synthesis of Chalcogenyl (Se/S)-Oxadiazoles
  publication-title: ChemsitrySelect
  doi: 10.1002/slct.201801213
– volume: 2021
  start-page: 7753857
  year: 2021
  ident: ref_39
  article-title: Mechanisms of Hydroxyurea-Induced Cellular Senescence: An Oxidative Stress Connection?
  publication-title: Oxidative Med. Cell Longev.
  doi: 10.1155/2021/7753857
– volume: 129
  start-page: 172
  year: 2011
  ident: ref_28
  article-title: The impact of redox and thiol status on the bone marrow: Pharmacological intervention strategies
  publication-title: Pharmacol. Ther.
  doi: 10.1016/j.pharmthera.2010.09.008
– ident: ref_36
– volume: 41
  start-page: 2904
  year: 2016
  ident: ref_46
  article-title: Chronic Melatonin Administration Reduced Oxidative Damage and Cellular Senescence in the Hippocampus of a Mouse Model of Down Syndrome
  publication-title: Neurochem. Res.
  doi: 10.1007/s11064-016-2008-8
– ident: ref_17
  doi: 10.3390/ijms21124346
– volume: 432
  start-page: 307
  year: 2004
  ident: ref_44
  article-title: Intrinsic tumour suppression
  publication-title: Nature
  doi: 10.1038/nature03098
SSID ssj0021415
Score 2.4412794
Snippet Imidazo[1,2-a]pyridines (IPs) have been studied regarding drug development. The objective of this work was to evaluate the antileukemic capacity of IP...
Imidazo[1,2 ]pyridines (IPs) have been studied regarding drug development. The objective of this work was to evaluate the antileukemic capacity of IP...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 893
SubjectTerms Antineoplastic Agents - pharmacology
Apoptosis
Bioavailability
Breast cancer
Cancer therapies
Cell cycle
Cell growth
Cell Proliferation
Cellular Senescence
Chemotherapy
chronic myeloid leukemia
DNA damage
Drug development
Humans
imidazo[1,2-a]pyridines
K562 Cells
Kinases
Leukemia
Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy
Leukemia, Myeloid
Oxidative Stress
Pyridines - pharmacology
selenide
Senescence
Toxicity
SummonAdditionalLinks – databaseName: ProQuest Central
  dbid: BENPR
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bb9MwFD6CDgleuA8CA_mBJ0S0xE7i-Alt1aYhQZkoSJMQinw5gYgs6ZoOUX797MQtK6C98BYlTmzrXO3jfB_AC82YkhhhmChUYaLTLMwpS8O0lNYAtYO_TXqyCT6Z5Ccn4thvuHX-WOXKJ_aO2rTa7ZHvUu5qhi4heD07Cx1rlKuuegqN67DlkMqSEWztH0yOP6yXXLGNT0Mtk9nF_e7pQDmLHc0dOaVgG9GoB-3_V6b554HJSxHo8M7_jv0u3Pa5J9kblOUeXMPmPtwcryjfHsDZ1AWhZW3zT0PenFZG_mo_x69oKL_MlvPKhjkkjuvD-hYyxromU-cptXMORDaGvP9ZmR5InEz7X1BI1RCPvkveLbFuK0Pe4vl326HsP9A9hE-HBx_HR6HnZAh1kkWLkJtUaJVpga7AqoyRlOnEzi1RzEZ_5DE1KFRJ7SUVSKWWkYpQKaZzymNk2zBq2gYfA1Em06mKMVeKJ3nMZGqTH6nt90qdiyQOIFrJptAesNzxZtSFXbg4cRZ_iTOAl-tXZgNax1WN953A1w0d0HZ_o51_LbzdFrGWaCcklM6MVWepRIY25-WYUk5LVQawsxJ54a2_K37LO4BHg-ase2FZxq0PFAHwDZ3aGMbmk6b61uN-izxzMeHJ1V0-hVvUJmLDNtEOjBbzc3wGN_SPRdXNn3sDuQCLcSCz
  priority: 102
  providerName: ProQuest
Title Selenylated Imidazo[1,2-a]pyridine Induces Cell Senescence and Oxidative Stress in Chronic Myeloid Leukemia Cells
URI https://www.ncbi.nlm.nih.gov/pubmed/36677949
https://www.proquest.com/docview/2767270951
https://pubmed.ncbi.nlm.nih.gov/PMC9860887
https://doaj.org/article/1caede99bc6d4beab96e1937e5272fbf
Volume 28
WOSCitedRecordID wos000918701700001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 1420-3049
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0021415
  issn: 1420-3049
  databaseCode: DOA
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 1420-3049
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0021415
  issn: 1420-3049
  databaseCode: 7X7
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 1420-3049
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0021415
  issn: 1420-3049
  databaseCode: BENPR
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Publicly Available Content Database
  customDbUrl:
  eissn: 1420-3049
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0021415
  issn: 1420-3049
  databaseCode: PIMPY
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/publiccontent
  providerName: ProQuest
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1bb9MwFD6CgQQvaNzDRuUHnhDREjuJ40dWbdokVioKUhFCkS8nIiJLR9shyq_fcZJWKyB44S1X2_K5x873AbywQhiNEYaJQRMmNs3CnIs0TEtNBmg9_G3Skk3I0SifTtX4GtWX3xPWwQN3E3cQW40OlTI2c9SeNipDSjokplzy0pTe-1LWsy6m-lIrprjUrWEKKuoPzjuqWVzw3JNSKrEVhVqw_j9lmL9ulLwWeY534V6fMrLX3VDvww1sHsCd4Zqp7SF8m_jYsaopbXTs9Lxy-ufsU_yKh_rzxWpeUXRC5ik6yCWwIdY1m3gHZ71NM9049vZH5Vr8bzZp_xxhVcN60Fx2tsJ6Vjn2Bi-_Uoe6bWDxCD4cH70fnoQ9lUJokyxahtKlyprMKvTrosY5zYVNJNV2RlDQRhlzmmRTcjrkCrm2OjIRGiNszmWM4jHsNLMGnwIzLrOpiTE3RiZ5LHRKOYu21F5pc5XEAUTrqS1sjzPu6S7qguoNL43iN2kE8HLzykUHsvG3hw-9vDYPenzs9gJpTdFrTfEvrQlgfy3tojfaRcGlX5b2OWcATzrBb3oRWSbJdakA5JZKbA1j-05TfWnhulWeeVf-7H-Mew_uer777hvQPuws55f4HG7b78tqMR_ATTmVA7h1eDQavxu0FkFn49Oz8ccr8hsXgA
linkProvider Directory of Open Access Journals
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Jb9NAFH4qKVK5sC-GAnOAC8KqPeNtDghBoGrUJERKkYoqZGZ5BgvXSZMUCD-K38iMl0AA9dYDN8sev_HY31tm3vh9AI8UY1Kgh24gUbqBCiM3oSx0w0wYBVS2_G1QkU3Ew2FyeMhHG_Cj_RfGbqtsbWJlqPVE2TXyHRrbnKENCJ5PT1zLGmWzqy2FRg2LfVx-NVO2-bPeK_N9H1O6-_qgu-c2rAKuCiJv4cY65EpGiqNNEUqtBWUqMJIDyYz_wtinGrnMqDmkHKlQwpMeSslUQmMfmZF7ATYDA_akA5uj3mD0bjXF840_rHOnjHFv57imuMU5TSwZJmdr3q8iCfhXZPvnBs3fPN7ulf_tXV2Fy01sTV7UynANNrC8DlvdltLuBpyMrZNdFia-1qR3nGvxfXLkP6WueD9dznLjxpFYLhNjO0kXi4KMrSdQ1vgRUWry5luuq0LpZFz9YkPykjTVhclgicUk16SPp59Nh6ISML8Jb89lxLegU05KvANE6kiF0sdEyjhIfCZCE9wJZeRlKuGB74DXYiFVTUF2ywtSpGZiZuGT_gUfB56sbpnW1UjOavzSAmzV0BYSr05MZh_Txi6lvhJoBsSlirRRVyF5hCamjzGkMc1k5sB2C7G0sW7z9Be-HLhdI3XVC4ui2Nh47kC8huG1x1i_UuafqrrmPImsz7t7dpcPYWvvYNBP-73h_j24RE3QWS-JbUNnMTvF-3BRfVnk89mDRjkJfDhvjP8ETjF_LA
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Jb9NAFB6VFgEX9sVQYA5wQVixZ7zNASFIiYjahkgBqQghM8szWLh2mqRA-Gn8Ot54CQRQbz1ws-zxPI_9vWXmjd9HyAPNuZLggRsoUG6gw8hNGA_dMJOogNqWvw1qsol4NEoODsR4g_zo_oWx2yo7m1gbalNpu0beY7HNGdqAoJe12yLGO4On0yPXMkjZTGtHp9FAZBeWX3H6Nn8y3MFv_ZCxwYvX_ZduyzDg6iDyFm5sQqFVpAXYdKEyRjKuA5QSKI6-DGKfGRAqY3jIBDCppac8UIrrhMU-cOz3DNnCkDxAHdsaD_fHb1fTPR99Y5NH5Vx4vcOG7hbmLLHEmIKvecKaMOBfUe6fmzV_836DS__ze7tMLrYxN33WKMkVsgHlVXK-31HdXSNHE-t8lwXG3YYOD3Mjv1fv_MfMle-ny1mO7h2o5ThBm0r7UBR0Yj2EtkaRytLQV99yUxdQp5P61xual7StOkz3l1BUuaF7cPwZBcq6g_l18uZURnyDbJZVCbcIVSbSofIhUSoOEp_LEIM-qbG_TCci8B3idbhIdVuo3fKFFClO2CyU0r-g5JBHq1umTZWSkxo_t2BbNbQFxusT1exj2tqr1NcScEBC6cigGkslIsBYP4aQxSxTmUO2O7ilrdWbp7-w5pCbDWpXUngUxWj7hUPiNTyvPcb6lTL_VNc7F0lkfeHtk0XeJ-cQ2OnecLR7h1xgGIs2K2XbZHMxO4a75Kz-ssjns3utnlLy4bQh_hMfXofs
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Selenylated+Imidazo%5B1%2C2-a%5Dpyridine+Induces+Cell+Senescence+and+Oxidative+Stress+in+Chronic+Myeloid+Leukemia+Cells&rft.jtitle=Molecules+%28Basel%2C+Switzerland%29&rft.au=Gabriella+Teles+Burkner&rft.au=Dh%C3%A9bora+Albuquerque+Dias&rft.au=Kamylla+Fernanda+Souza+de+Souza&rft.au=Anna+J%C3%BAlia+Papa+de+Ara%C3%BAjo&rft.date=2023-01-01&rft.pub=MDPI+AG&rft.eissn=1420-3049&rft.volume=28&rft.issue=2&rft.spage=893&rft_id=info:doi/10.3390%2Fmolecules28020893&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_1caede99bc6d4beab96e1937e5272fbf
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1420-3049&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1420-3049&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1420-3049&client=summon